Pharmaceutical

Biocytogen and Radiance partner for bispecific antibody-drug conjugate

Biocytogen Pharmaceuticals and Radiance Biopharma have signed an exclusive option and licence agreement for a BsADC.

Jan 9, 2024 - 18:00
Biocytogen and Radiance partner for bispecific antibody-drug conjugate
Biocytogen Pharmaceuticals and Radiance Biopharma have signed an exclusive option and licence agreement for a BsADC.
Read the original article

Tags:

Previous Article

MSD acquires Harpoon for $680m to strengthen T-cell engager armoury

Next Article

BIOS Health to launch precision medicine centre in California, US

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Philips to stop selling sleep apnea machines in U.S. under tentative agreement with FDA, DOJ

Philips to stop selling sleep apnea machines in U.S. un...

Jan 30, 2024

STAT+: GOP senator probes drug discount programs at Cleveland Clinic, Bon Secours

STAT+: GOP senator probes drug discount programs at Cle...

Sep 28, 2023

Opinion: The court system is not ready for child custody disputes over gender-affirming care

Opinion: The court system is not ready for child custod...

Jun 12, 2023